SLC39A1 regulates the malignant potential of prostate cancer cells by inhibiting the nuclear factor kappa B (NF-κB) signaling pathway, and SLC39A1 may play a role as a tumor suppressor gene in prostate cancer [18]. This evidence concerns the gene SLC39A1 and prostate carcinoma.